Department of Health and Human Services October 21, 2024 – Federal Register Recent Federal Regulation Documents

Proposed Information Collection Activity; Federal Tax Refund Offset, Administrative Offset, and Passport Denial
Document Number: 2024-24228
Type: Notice
Date: 2024-10-21
Agency: Department of Health and Human Services, Administration for Children and Families
The Office of Child Support Services (OCSS), Administration for Children and Families (ACF), is requesting the federal Office of Management and Budget (OMB) to approve the Federal Tax Refund Offset, Administrative Offset, and Passport Denial with minor edits to change "Office of Child Support Enforcement (OCSE)" to "Office of Child Support Services (OCSS)" and minor formatting enhancements. The current OMB approval expires on June 30, 2025.
Final Scientific Integrity Policy of the National Institutes of Health
Document Number: 2024-24225
Type: Notice
Date: 2024-10-21
Agency: Department of Health and Human Services, National Institutes of Health
The National Institutes of Health (NIH) is issuing this Final NIH Scientific Integrity Policy to promote a continuing culture of scientific integrity at NIH. This Policy codifies NIH's long-standing expectations to preserve scientific integrity throughout all NIH activities, establishes key roles and responsibilities for those who will lead the agency's scientific integrity program, and, as appropriate, establishes relevant reporting and evaluation mechanisms.
National Institute on Deafness and Other Communication Disorders; Notice of Closed Meeting
Document Number: 2024-24199
Type: Notice
Date: 2024-10-21
Agency: Department of Health and Human Services, National Institutes of Health
Determination of Regulatory Review Period for Purposes of Patent Extension; Vyndaqel
Document Number: 2024-24188
Type: Notice
Date: 2024-10-21
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA or the Agency) has determined the regulatory review period for VYNDAQEL and is publishing this notice of that determination as required by law. FDA has made the determination because of the submission of an application to the Director of the U.S. Patent and Trademark Office (USPTO), Department of Commerce, for the extension of a patent which claims that human drug product.
Determination of Regulatory Review Period for Purposes of Patent Extension; Vyndamax
Document Number: 2024-24187
Type: Notice
Date: 2024-10-21
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA or the Agency) has determined the regulatory review period for VYNDAMAX and is publishing this notice of that determination as required by law. FDA has made the determination because of the submission of applications to the Director of the U.S. Patent and Trademark Office (USPTO), Department of Commerce, for the extension of a patent which claims that human drug product.
Agency Information Collection Activities: Proposed Collection; Comment Request
Document Number: 2024-24266
Type: Notice
Date: 2024-10-21
Agency: Centers for Medicare & Medicaid Services, Department of Health and Human Services
The Centers for Medicare & Medicaid Services (CMS) is announcing an opportunity for the public to comment on CMS' intention to collect information from the public. Under the Paperwork Reduction Act of 1995 (PRA), federal agencies are required to publish notice in the Federal Register concerning each proposed collection of information (including each proposed extension or reinstatement of an existing collection of information) and to allow 60 days for public comment on the proposed action. Interested persons are invited to send comments regarding our burden estimates or any other aspect of this collection of information, including the necessity and utility of the proposed information collection for the proper performance of the agency's functions, the accuracy of the estimated burden, ways to enhance the quality, utility, and clarity of the information to be collected, and the use of automated collection techniques or other forms of information technology to minimize the information collection burden.
Agency Information Collection Activities: Submission for OMB Review; Comment Request
Document Number: 2024-24264
Type: Notice
Date: 2024-10-21
Agency: Centers for Medicare & Medicaid Services, Department of Health and Human Services
The Centers for Medicare & Medicaid Services (CMS) is announcing an opportunity for the public to comment on CMS' intention to collect information from the public. Under the Paperwork Reduction Act of 1995 (PRA), federal agencies are required to publish notice in the Federal Register concerning each proposed collection of information, including each proposed extension or reinstatement of an existing collection of information, and to allow a second opportunity for public comment on the notice. Interested persons are invited to send comments regarding the burden estimate or any other aspect of this collection of information, including the necessity and utility of the proposed information collection for the proper performance of the agency's functions, the accuracy of the estimated burden, ways to enhance the quality, utility, and clarity of the information to be collected, and the use of automated collection techniques or other forms of information technology to minimize the information collection burden.
Determination of Regulatory Review Period for Purposes of Patent Extension; Gore Tag Thoracic Branch Endoprosthesis
Document Number: 2024-24287
Type: Notice
Date: 2024-10-21
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA or the Agency) has determined the regulatory review period for GORE TAG THORACIC BRANCH ENDOPROSTHESIS and is publishing this notice of that determination as required by law. FDA has made the determination because of the submission of applications to the Director of the U.S. Patent and Trademark Office (USPTO), Department of Commerce, for the extension of patents which claims that medical device.
Agency Information Collection Activities: Submission for OMB Review; Comment Request
Document Number: 2024-24250
Type: Notice
Date: 2024-10-21
Agency: Department of Health and Human Services, Substance Abuse and Mental Health Services Administration
Determination of Regulatory Review Period for Purposes of Patent Extension; Pascal Precision Transcatheter Valve Repair System
Document Number: 2024-24244
Type: Notice
Date: 2024-10-21
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA or the Agency) has determined the regulatory review period for PASCAL PRECISION TRANSCATHETER VALVE REPAIR SYSTEM and is publishing this notice of that determination as required by law. FDA has made the determination because of the submission of an application to the Director of the U.S. Patent and Trademark Office (USPTO), Department of Commerce, for the extension of a patent which claims that medical device.
National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting
Document Number: 2024-24242
Type: Notice
Date: 2024-10-21
Agency: Department of Health and Human Services, National Institutes of Health
Office of the Director; Notice of Closed Meeting
Document Number: 2024-24241
Type: Notice
Date: 2024-10-21
Agency: Department of Health and Human Services, National Institutes of Health
Center for Scientific Review and National Institute of Allergy and Infectious Diseases; Amended Notice of Closed Meeting
Document Number: 2024-24240
Type: Notice
Date: 2024-10-21
Agency: Department of Health and Human Services, National Institutes of Health
National Institute of Mental Health; Notice of Closed Meetings
Document Number: 2024-24239
Type: Notice
Date: 2024-10-21
Agency: Department of Health and Human Services, National Institutes of Health
Office of the Director, National Institutes of Health; Notice of Meeting
Document Number: 2024-24238
Type: Notice
Date: 2024-10-21
Agency: Department of Health and Human Services, National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Document Number: 2024-24237
Type: Notice
Date: 2024-10-21
Agency: Department of Health and Human Services, National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Document Number: 2024-24236
Type: Notice
Date: 2024-10-21
Agency: Department of Health and Human Services, National Institutes of Health
Proposed Data Collection Submitted for Public Comment and Recommendations
Document Number: 2024-24304
Type: Notice
Date: 2024-10-21
Agency: Centers for Disease Control and Prevention, Department of Health and Human Services
The Centers for Disease Control and Prevention (CDC), as part of its continuing effort to reduce public burden and maximize the utility of government information, invites the general public and other federal agencies the opportunity to comment on a proposed and/or continuing information collection, as required by the Paperwork Reduction Act of 1995. This notice invites comment on a proposed information collection project titled 2024 Marburg Airport Entry Questionnaires. This information collection is intended to assess risk for infection or exposure to Marburg in travelers coming to the United States from areas affected by an outbreak of Marburg originating in Rwanda.
Proposed Data Collection Submitted for Public Comment and Recommendations
Document Number: 2024-24303
Type: Notice
Date: 2024-10-21
Agency: Centers for Disease Control and Prevention, Department of Health and Human Services
The Centers for Disease Control and Prevention (CDC), as part of its continuing effort to reduce public burden and maximize the utility of government information, invites the general public and other Federal agencies the opportunity to comment on a proposed information collection, as required by the Paperwork Reduction Act of 1995. This notice invites comment on a proposed information collection project titled Overdose Response Strategy Data Collection. This data collection will allow Overdose Response Strategy (ORS) teams and their partners to provide critical data to CDC for program monitoring and achieve the goal of supporting public health and public safety partnerships to reduce drug overdose.
Agency Forms Undergoing Paperwork Reduction Act Review
Document Number: 2024-24302
Type: Notice
Date: 2024-10-21
Agency: Centers for Disease Control and Prevention, Department of Health and Human Services
Agency Forms Undergoing Paperwork Reduction Act Review
Document Number: 2024-24301
Type: Notice
Date: 2024-10-21
Agency: Centers for Disease Control and Prevention, Department of Health and Human Services
Proposed Data Collection Submitted for Public Comment and Recommendations
Document Number: 2024-24308
Type: Notice
Date: 2024-10-21
Agency: Centers for Disease Control and Prevention, Department of Health and Human Services
The Centers for Disease Control and Prevention (CDC), as part of its continuing effort to reduce public burden and maximize the utility of government information, invites the general public and other federal agencies the opportunity to comment on a continuing information collection, as required by the Paperwork Reduction Act of 1995. This notice invites comment on a proposed information collection project titled CryptoNet Case Report Form. The CryptoNet Case Report Form will be used by federal, state, and local public health officials responsible for conducting interviews with reported cases of cryptosporidiosis in their jurisdiction in order to systematically assess core exposure elements and risk factors among cases of cryptosporidiosis.
Proposed Data Collection Submitted for Public Comment and Recommendations
Document Number: 2024-24307
Type: Notice
Date: 2024-10-21
Agency: Centers for Disease Control and Prevention, Department of Health and Human Services
The Centers for Disease Control and Prevention (CDC), as part of its continuing effort to reduce public burden and maximize the utility of government information, invites the general public and other federal agencies the opportunity to comment on a continuing information collection, as required by the Paperwork Reduction Act of 1995. This notice invites comment on the Million Hearts[supreg] Hospital & Health System Recognition Program. This program recognizes institutions working systematically to improve the cardiovascular health of the population and communities they serve.
Proposed Data Collection Submitted for Public Comment and Recommendations
Document Number: 2024-24306
Type: Notice
Date: 2024-10-21
Agency: Centers for Disease Control and Prevention, Department of Health and Human Services
The Centers for Disease Control and Prevention (CDC), as part of its continuing effort to reduce public burden and maximize the utility of government information, invites the general public and other federal agencies the opportunity to comment on a continuing information collection, as required by the Paperwork Reduction Act of 1995. This notice invites comment on a proposed information collection project titled National Program of Cancer Registries Program Evaluation Instrument (NPCR-PEI). The NPCR-PEI is a web-based survey instrument designed to evaluate NPCR-funded registries' operational attributes and their progress towards meeting program standards.
Proposed Data Collection Submitted for Public Comment and Recommendations
Document Number: 2024-24305
Type: Notice
Date: 2024-10-21
Agency: Centers for Disease Control and Prevention, Department of Health and Human Services
The Centers for Disease Control and Prevention (CDC), as part of its continuing effort to reduce public burden and maximize the utility of government information, invites the general public and other federal agencies the opportunity to comment on a proposed information collection, as required by the Paperwork Reduction Act of 1995. This notice invites comment on a proposed information collection project titled 2024 Marburg Traveler Monitoring Assessment. This information collection is intended to determine the number of travelers coming to the United States from Rwanda, where a Marburg outbreak is occurring, that are enrolled by jurisdictions into monitoring, if recommended, and the proportion of travelers that completed monitoring.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.